ACA Countdown: Details Emerging On Exchanges, Medicaid Expansion
This article was originally published in The Pink Sheet Daily
Executive Summary
Open enrollment in state exchange plans kicks off Oct. 1 and expanded Medicaid eligibility Jan. 1, and many states offer a preliminary view of how coverage will play out under the Affordable Care Act in 2014.
You may also be interested in...
Rx Spending Expected To Grow 5% In First Year of Expanded Health Coverage, CMS Predicts
CMS projects the year-over-year growth in retail prescription drug spending to jump from a negative to flat growth in 2012 and 2013 to more than 5% in 2014 and nearly 7% in 2015, largely due to expanded health care coverage under the Affordable Care Act.
Biopharma Sizes Up The Affordable Care Act: Buyer’s Remorse Or Winner’s Curse?
Three years into the ACA, the biopharma industry takes stock of its near-term wins and losses as the law’s critical expanded insurance coverage takes effect beginning in 2014. Pharma still isn’t sure whether the increase in covered lives from the exchanges will boost prescription sales enough to offset the rebates, taxes, and fees it agreed to pay out, or what kind of patients constitute this new market.
Pink Sheet Podcast: COVID Vaccine In Adolescents, CMS Drug Pricing Moves, Standard Care In Clinical Trials
Pink Sheet reporters and editors discuss the US FDA decision to lower the eligibility age for the Pfizer/BioNTech COVID-19 vaccine, CMS drug pricing project plans, and mid-stream standard of care changes in drug development.